HA
GILD icon

Harfst & Associates’s Gilead Sciences GILD Stock Holding History

Harfst & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,022
Closed -$453K – 141
2021
Q1 		$453K Sell
7,022
-13,893
-66% -$896K 0.14% 112
2020
Q4 		$1.22M Buy
20,915
+5,380
+35% +$325K 0.45% 40
2020
Q3 		$981K Sell
15,535
-152
-1% -$10.5K 0.42% 38
2020
Q2 		$1.21M Buy
15,687
+103
+0.7% +$7.89K 0.52% 23
2020
Q1 		$1.17M Buy
15,584
+11,744
+306% +$811K 0.59% 14
2019
Q4 		$249K Sell
3,840
-56
-1% -$3.65K 0.1% 89
2019
Q3 		$246K Buy
+3,896
New +$255K 0.1% 88
2017
Q3 		– Sell
-384
Closed -$27K – 126
2017
Q2 		$27K Buy
384
+116
+43% +$7.72K 0.01% 160
2017
Q1 		$18K Buy
+268
New +$18.8K 0.01% 193
2016
Q1 		– Sell
-58
Closed -$5K – 127
2015
Q4 		$5K Buy
58
+10
+21% +$1.04K ﹤0.01% 261
2015
Q3 		$5K Hold
48
– – ﹤0.01% 252
2015
Q2 		$6K Buy
+48
New +$5.25K ﹤0.01% 290

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Harfst & Associates's GILD Position: Q2 2021 in Review

Harfst & Associates sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 7,022 shares — an estimated $453K sold.

Harfst & Associates first reported a position in GILD in Q2 2015 and held it in 12 quarters. The position peaked at $1.22M in Q4 2020. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Harfst & Associates reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Harfst & Associates sold 7,022 Gilead Sciences shares in Q2 2021, an estimated $453K.
  • Harfst & Associates first reported a position in Gilead Sciences in Q2 2015 and held it in 12 quarters.
  • Harfst & Associates's Gilead Sciences position peaked at $1.22M in Q4 2020.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Harfst & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.